By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Advaxis, Inc. 

The Technology Centre of New Jersey
675 U.S. Route One, South
North Brunswick  New Jersey  08902   U.S.A.
Phone: 732-545-1590 Fax: 732-545-1084



Company News
Advaxis, Inc.'s Scientific Founder To Present On ADXS-HER2 At World Congress On Breast Cancer 2015 7/29/2015 10:24:36 AM
Advaxis, Inc. Expands Intellectual Property For Lm Technology Platform In HER2 7/21/2015 7:44:48 AM
Advaxis, Inc. Appoints Dr. Shelonitda S. Rose As Vice President, Clinical Development 7/8/2015 7:46:15 AM
Advaxis, Inc.'s President And Chief Executive Officer Daniel J. O'Connor Receives 2015 Ernst & Young Entrepreneur Of The Year In New Jersey 6/29/2015 9:47:22 AM
Advaxis, Inc. Provides 2015 Half-Year Review And Outlook 6/25/2015 11:23:08 AM
Advaxis, Inc. Selected For Inclusion In Russell Global And Russell 3000 Indexes 6/22/2015 8:40:42 AM
Advaxis, Inc. To Hold Business Update Conference Call On June 25, 2015 6/19/2015 7:47:10 AM
Advaxis, Inc. Submits Special Protocol Assessment Request To FDA For ADXS-HPV Phase 3 Clinical Trial In Cervical Cancer 6/15/2015 7:28:55 AM
Advaxis, Inc.'s Cancer Immunotherapy Delays Progression Of HER2+ Canine Osteosarcoma 6/8/2015 8:45:32 AM
Advaxis, Inc. Announces FDA Clearance Of Investigational New Drug Application For Phase 2 Study Of ADXS-HPV And Incyte (INCY)'s Epacadostat For The Treatment Of HPV-Associated Early Stage Cervical Cancer 6/1/2015 6:38:13 AM